Institutional Ownership Keros Therapeutics, Inc. (KROS)
This table provides information about the institutional ownership of Keros Therapeutics, Inc. (KROS). We have compiled data on the 156 institutions that hold shares in the stock, with a total of 38.6 Million shares, which have been reported (via 13F filing form) to have a value of $615 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Brevan Howard Capital Management LP
St. Helier, Y9 |
Aug 14, 2025 Q2 2025 |
70,149
shares
|
$1.09 Million
0.01% of portfolio
|
Q2 2025
Added 6.54%
|
|
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
Aug 13, 2025 Q2 2025 |
64,581
shares
|
$1.01 Million
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Russell Investments Group, Ltd.
|
Aug 13, 2025 Q2 2025 |
61,743
shares
|
$961,955
0.0% of portfolio
|
Q2 2025
Added 648.04%
|
|
|
Gsa Capital Partners LLP
London, X0 |
Jul 22, 2025 Q2 2025 |
61,455
shares
|
$957,468
0.06% of portfolio
|
Q2 2025
New holding
|
|
|
Jane Street Group, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
57,281
shares
|
$892,437
0.0% of portfolio
|
Q2 2025
Added 22.02%
|
|
|
Algert Global LLC
San Francisco, CA |
Aug 13, 2025 Q2 2025 |
55,570
shares
|
$865,780
0.02% of portfolio
|
Q2 2025
Added 102.22%
|
|
|
Rafferty Asset Management, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
54,294
shares
|
$845,900
0.0% of portfolio
|
Q2 2025
Reduced 1.88%
|
|
|
Xtx Topco LTD
London, X0 |
Aug 12, 2025 Q2 2025 |
54,145
shares
|
$843,579
0.03% of portfolio
|
Q2 2025
Added 12.52%
|
|
|
Mackenzie Financial Corp
Toronto Ontario, A6 |
Aug 13, 2025 Q2 2025 |
53,877
shares
|
$839,403
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
High Vista Strategies LLC
Boston, MA |
Aug 14, 2025 Q2 2025 |
52,618
shares
|
$819,788
0.29% of portfolio
|
Q2 2025
Added 0.98%
|
|
|
Rhumbline Advisers
Boston, MA |
Aug 12, 2025 Q2 2025 |
51,815
shares
|
$807,277
0.0% of portfolio
|
Q2 2025
Added 16.0%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
48,415
shares
|
$754,305
0.0% of portfolio
|
Q2 2025
Added 12.0%
|
|
|
Quadrature Capital LTD
London, X0 |
Aug 13, 2025 Q2 2025 |
47,000
shares
|
$732,260
0.01% of portfolio
|
Q2 2025
Added 62.79%
|
|
|
Invesco Ltd.
Atlanta, GA |
Aug 13, 2025 Q2 2025 |
43,395
shares
|
$676,094
0.0% of portfolio
|
Q2 2025
Added 30.45%
|
|
|
Los Angeles Capital Management LLC
|
Aug 06, 2025 Q2 2025 |
41,709
shares
|
$649,826
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Summit Tx Capital, L.P.
Fort Worth, TX |
Aug 14, 2025 Q2 2025 |
40,000
shares
|
$623,200
0.02% of portfolio
|
Q2 2025
Added 29.52%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Aug 14, 2025 Q2 2025 |
38,677
shares
|
$602,587
0.0% of portfolio
|
Q2 2025
Reduced 85.85%
|
|
|
Ubs Oconnor LLC
Chicago, IL |
Aug 14, 2025 Q2 2025 |
37,891
shares
|
$590,341
0.02% of portfolio
|
Q2 2025
Reduced 67.2%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
36,636
shares
|
$570,788
0.0% of portfolio
|
Q1 2025
Reduced 76.39%
|
|
|
Caption Management, LLC
Oklahoma City, OK |
Aug 14, 2025 Q2 2025 |
36,078
shares
|
$562,095
0.01% of portfolio
|
Q2 2025
Reduced 66.28%
|
|
|
Citigroup Inc
|
Aug 11, 2025 Q2 2025 |
34,379
shares
|
$535,624
0.0% of portfolio
|
Q2 2025
Reduced 52.09%
|
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
34,162
shares
|
$532,243
0.0% of portfolio
|
Q1 2024
Added 28.23%
|
|
|
Jefferies Group LLC
New York, NY |
Sep 21, 2023 Q3 2022 |
29,319
shares
|
$456,790
0.01% of portfolio
|
Q3 2022
Added 134.55%
|
|
|
Alliancebernstein L.P.
New York, NY |
Aug 14, 2025 Q2 2025 |
27,810
shares
|
$433,279
0.0% of portfolio
|
Q2 2025
Reduced 2.46%
|
|
|
Polymer Capital Management (Us) LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
27,181
shares
|
$423,479
0.04% of portfolio
|
Q2 2025
Added 135.52%
|